RK STRATEGIES, INC.

Lobbying for RECCE PHARMACEUTICALS LTD · Pharmaceutical Company - Anti-infectives

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

General healthcare/wound care issues

Defense

General biodefense/wound care issues

Veterans

General wound care issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.